Chloraprep With Tint is a drug owned by Becton Dickinson And Co. It is protected by 8 US drug patents filed in 2013. Out of these, 1 drug patents are active and 7 have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 25, 2027. Details of Chloraprep With Tint's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US7422388 | Applicator for coloring antiseptic |
Apr, 2027
(2 years from now) | Active |
| US6991393 | Liquid applicator for coloring a liquid |
Mar, 2023
(1 year, 8 months ago) |
Expired
|
| US6991394 | Liquid applicator with a mechanism for fracturing multiple ampoules |
Jan, 2024
(9 months ago) |
Expired
|
| US7182536 | Antiseptic applicator with mechanism for fracturing multiple ampoules |
Dec, 2023
(10 months ago) |
Expired
|
| US6729786 | Liquid applicator for coloring a liquid |
Mar, 2023
(1 year, 8 months ago) |
Expired
|
| US7241065 | Applicator for coloring antiseptic |
Mar, 2023
(1 year, 8 months ago) |
Expired
|
| US6536975 | Liquid applicator with opposed wings |
Nov, 2020
(4 years ago) |
Expired
|
| US5690958 | Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life |
Sep, 2016
(8 years ago) |
Expired
|
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Chloraprep With Tint's patents.
Latest Legal Activities on Chloraprep With Tint's Patents
Given below is the list of recent legal activities going on the following patents of Chloraprep With Tint.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Feb, 2020 | US7422388 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Dec, 2018 | US7241065 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Jul, 2018 | US7182536 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 26 Aug, 2010 | US7182536 |
| Change in Power of Attorney (May Include Associate POA) Critical | 29 Sep, 2009 | US6729786 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Sep, 2009 | US7241065 |
| Change in Power of Attorney (May Include Associate POA) Critical | 28 Sep, 2009 | US6991393 |
| Change in Power of Attorney (May Include Associate POA) Critical | 24 Sep, 2009 | US6991394 |
| Change in Power of Attorney (May Include Associate POA) Critical | 24 Sep, 2009 | US7182536 |
| Correspondence Address Change Critical | 23 Sep, 2009 | US7241065 |
US patents provide insights into the exclusivity only within the United States, but Chloraprep With Tint is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Chloraprep With Tint's family patents as well as insights into ongoing legal events on those patents.
Chloraprep With Tint's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Chloraprep With Tint's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 25, 2027 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Chloraprep With Tint Generics:
There are no approved generic versions for Chloraprep With Tint as of now.
Alternative Brands for Chloraprep With Tint
Chloraprep With Tint which is used for sterilizing the patient's skin before surgery., has several other brand drugs in the same treatment category and using the same active ingredient (Chlorhexidine Gluconate; Isopropyl Alcohol). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||
|---|---|---|---|---|
| Zurex Pharma |
| |||
Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Chlorhexidine Gluconate; Isopropyl Alcohol. Given below is the list of those drugs and companies owning them.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| 3m Health Care |
| |||
| Becton Dickinson Co |
| |||
| Prof Dspls |
|
About Chloraprep With Tint
Chloraprep With Tint is a drug owned by Becton Dickinson And Co. It is used for sterilizing the patient's skin before surgery. Chloraprep With Tint uses Chlorhexidine Gluconate; Isopropyl Alcohol as an active ingredient. Chloraprep With Tint was launched by Becton Dickinson Co in 2000.
Approval Date:
Chloraprep With Tint was approved by FDA for market use on 14 July, 2000.
Active Ingredient:
Chloraprep With Tint uses Chlorhexidine Gluconate; Isopropyl Alcohol as the active ingredient. Check out other Drugs and Companies using Chlorhexidine Gluconate; Isopropyl Alcohol ingredient
Treatment:
Chloraprep With Tint is used for sterilizing the patient's skin before surgery.
Dosage:
Chloraprep With Tint is available in sponge form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2%;70% (26ML) | SPONGE | Over the counter | TOPICAL |
| 2%;70% (10.5ML) | SPONGE | Over the counter | TOPICAL |
| 2%;70% (3ML) | SPONGE | Over the counter | TOPICAL |